Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

被引:9
|
作者
Xu, Hongen [1 ]
You, Guangxian [2 ]
Zhang, Minjun [1 ,3 ]
Song, Tao [1 ]
Zhang, Haibo [1 ]
Yang, Jia [1 ]
Jia, Yongshi [1 ]
Tang, Jianming [1 ]
Liang, Xiaodong [1 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Canc Ctr,Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
[2] Taizhou Canc Hosp, Dept Radiat Oncol, Taizhou 317502, Peoples R China
[3] Bengbu Med Coll, Grad Dept, 2600 Donghai Ave, Bengbu 233000, Peoples R China
关键词
Rectal cancer; Lymphocyte counts; Disease-free survival; Chemoradiotherapy; ACUTE HEMATOLOGIC TOXICITY; DOSIMETRIC PARAMETERS; CERVICAL-CANCER; LYMPHOPENIA; CHEMORADIATION; CHEMOTHERAPY; PREDICTORS; MARKER; TUMOR;
D O I
10.1186/s12957-019-1747-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer is the fourth most common cancer globally and neoadjuvant concurrent chemoradiotherapy (nCRT) and surgery are the standard treatments for locally advanced colorectal carcinoma. This study investigated the association between dynamic changes in absolute lymphocyte counts (ALCs) and disease-free survival (DFS) in rectal cancer patients receiving nCRT and identified factors associated with these changes. Methods We retrospectively examined 34 patients with locally advanced rectal cancer who received nCRT followed by surgery and adjuvant chemotherapy. The association between ALCs and DFS and that between ALCs and downstaging were analyzed and potential clinical- and treatment-related factors related to dynamic changes in ALCs were subsequently evaluated. The patient eligibility criteria were as follows: pathologically confirmed rectal adenocarcinoma, clinical stages II-III, >= 18 years of age, and so on. Pre-RTL was defined as ALCs obtained before the initiation of nCRT and pre-SL was defined as ALCs obtained before surgery. We measured pre-SL to pre-RTL ratio (pre-SLR), DFS, and ALCs. Results The median ALC declined significantly during nCRT. A lower pre-SLR was associated with poorer DFS with statistical significance in Kaplan-Meier (p = 0.007), univariate regression (hazard ratio [HR] = 6.287, 95% confidence interval [CI] 1.374-28.781, p = 0.018), and multivariable regression (HR = 7.347, 95% CI 1.595-33.850, p = 0.011) analyses. Neither patient characteristics nor treatment-related factors were related to downstaging. The pelvic bone marrow (PBM) volume receiving at least 30 Gy (V30) was significantly associated with pre-SLR in the univariate (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) and multivariable (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) regression analyses. Limitations Our study had several limitations. The sample size was small and the study was performed in a selected population, which may limit the generalization of the findings. Conclusions Radiotherapy had a profound impact on the change in ALCs. A lower pre-SLR was significantly associated with poorer DFS in rectal cancer patients receiving nCRT. The V30 of PBM was a predictor of pre-SLR.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
    Hongen Xu
    Guangxian You
    Minjun Zhang
    Tao Song
    Haibo Zhang
    Jia Yang
    Yongshi Jia
    Jianming Tang
    Xiaodong Liang
    World Journal of Surgical Oncology, 17
  • [2] Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Poor Survival in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
    Ke, T. M.
    Yang, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E166 - E166
  • [3] High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
    Ke, Te-Min
    Lin, Li-Ching
    Huang, Chun-Che
    Chien, Yu-Wen
    Ting, Wei-Chen
    Yang, Ching-Chieh
    MEDICINE, 2020, 99 (17) : E19877
  • [4] Impact on overall survival and disease-free survival of adjuvant chemotherapy after neoadjuvant chemoradiotherapy for rectal cancer
    de Castro, Rafael Amaral
    Paiva, Carlos Eduardo
    Saad-Hossne, Rogerio
    Michelin, Odair Carlito
    Souza, Cristiano de Padua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy
    Cebrian, Arancha
    Gomez del Pulgar, Teresa
    Jesus Fernandez-Acenero, Maria
    Borrero-Palacios, Aurea
    del Puerto-Nevado, Laura
    Martinez-Useros, Javier
    Pablo Marin-Arango, Juan
    Carames, Cristina
    Vega-Bravo, Ricardo
    Rodriguez-Remirez, Maria
    Manzarbeitia, Felix
    Garcia-Foncillas, Jesus
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (12) : 1133 - 1137
  • [6] Pre-CCRT Systemic Inflammation Index (SII) and Neutrophil-To-Lymphocyte Ratio (NLR) are Better Than Platelet-To-Lymphocyte Ratio (PLR) as the Predictors for pCR in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy (CCRT)
    Ke, T. M.
    Yang, C. C.
    Huang, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E629 - E629
  • [7] Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
    Juliana Schwaab
    Karoline Horisberger
    Philipp Ströbel
    Beatrice Bohn
    Deniz Gencer
    Georg Kähler
    Peter Kienle
    Stefan Post
    Frederik Wenz
    Wolf-Karsten Hofmann
    Ralf-Dieter Hofheinz
    Philipp Erben
    BMC Cancer, 11
  • [8] Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
    Schwaab, Juliana
    Horisberger, Karoline
    Stroebel, Philipp
    Bohn, Beatrice
    Gencer, Deniz
    Kaehler, Georg
    Kienle, Peter
    Post, Stefan
    Wenz, Frederik
    Hofmann, Wolf-Karsten
    Hofheinz, Ralf-Dieter
    Erben, Philipp
    BMC CANCER, 2011, 11
  • [9] Pre-Treatment and Post-Treatment Neutrophil-to-Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
    Delikgoz Soykut, Ela
    Kemal, Yasemin
    Odabasi, Eylem
    Sahin, Nilgun
    Keskinkilic Yagiz, Betul
    Yazicioglu, Irem Melike
    Aytac Arslan, Suheyla
    Guney, Vildiz
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2022, 37 (02): : 139 - 149
  • [10] Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
    Karaca, Mustafa
    Salim, Ece
    Alemdar, Mustafa Serkan
    Karaca, Ozge Deniz
    Arici, Mustafa Ozgur
    MEDICAL SCIENCE MONITOR, 2024, 30